2023 Grand Finals & Showcase


Headquartered in Los Angeles, MedTech Innovator is the world’s largest accelerator of startups in medical devices, digital health, and in vitro diagnostics. It is the premier non-profit startup accelerator in the medical technology industry globally. By the end of 2023 more than 600 startups will have graduated from the program globally. Todate, these companies have gone on to raise more than US$ 7 billion in follow-on funding.

MedTech Innovator Asia Pacific Accelerator Program is an annual program, run in partnership with APACMed, that provides 20 best-in-class startups with high-profile visibility to healthcare strategics, investors, stakeholders, and decision-makers, access to a network of mentors and peers, and participation in a customized virtual curriculum.

Selected startups receive mentorship and coaching to help accelerate growth and scale across Asia Pacific and beyond through one-on-one matching with one or more mentors from our corporate partner organizations, including Johnson & Johnson, Olympus, Teleflex, B Braun Medical, Siemens Healthineers, Cambridge Consultants, Jabil Healthcare and many more. The MedTech Innovator Asia Pacific Cohort startups will compete for US$ 300,000 in non-dilutive cash and other in-kind awards at the APACMed MedTech Forum on 5th December 2023.

Acceleration Partners

Innovation Partners

Ecosystem Partner


As part of the Accelerator program, participating startups have developed their own 1-minute introductory videos and take part in the annual MedTech Innovator APAC Best Video Competition. Links to these short videos can be found below. The winner will be announced at the Grand Finals event at the APACMed MedTech Forum on 5th December.


MedTech Innovator 2023 Agenda

Commencing with an overview of MedTech Innovator Awards, this session will feature compelling pitches from top-selected start-ups. The session will also witness an enlightening dialogue with industry leaders, sharing their cutting-edge product/services, providing valuable insights into the collaborative dynamics shaping the MedTech landscape.

1000 – 1015 hrs


by Fredrik Nyberg, Managing Director, MTI APAC

1015 – 1105 hrs

Next-Gen Surgical & Infection Control

FlexPerc Medical (United States), Jdot Medtech (China), NICE Surgical (Singapore), Vivo Surgical (Singapore), Weinnovate Biosolutions (India)

1105 – 1130 hrs

Orthopaedics & Rehabilitation

Astron Medtech (United States), Kinexcs (Singapore)

1130 – 1155 hrs

Orthopaedics & Rehabilitation

Lifespans (Hong Kong), Ossfila Technology (Hong Kong)

1155 – 1340 hrs

Olympus Asia Pacific Innovation Program

BioCliq (India), NDR Medical (Singapore), SONIRE Therapeutics (Japan), Vesica AI (United States)

1340 – 1445 hrs

Neurology & Interventional Cardiology

Gbrain (South Korea), Genlight MedTech (China), Healium Medical (Israel), Medipixel (South Korea), Neurowyzr (Singapore), PrimaNova (Hong Kong)

1445 – 1600 hrs

In-Vitro Diagnostics

Accuster Technologies (India), Biotome (Australia), MedySapiens (South Korea), Module Innovations (India), Thrixen (Singapore)